Risk Factors Associated with Trastuzumab-induced Cardiotoxicity in Patients with Human Epidermal Growth Factor Receptor 2-positive Breast Cancer

CONTEXT: Although trastuzumab is a highly effective and selective targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer, the drug-induced cardiotoxicity may confine its usefulness in patients. AIM: To explore risk factors associated with the development of cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Razaq, Wesam, Alzahrani, Mohammed, Al Yami, Majed, Almugibl, Faisal, Almotham, Mohammed, Alregaibah, Razan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791087/
https://www.ncbi.nlm.nih.gov/pubmed/31619917
http://dx.doi.org/10.4103/jpbs.JPBS_276_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791087/
https://www.ncbi.nlm.nih.gov/pubmed/31619917
http://dx.doi.org/10.4103/jpbs.JPBS_276_18

Ejemplares similares